Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a site revision note: 'Revision: v3.3.4' and removed 'Revision: v3.3.3'; no study data, eligibility criteria, outcomes, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:21:54.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Locations now include Emilia-Romagna, Lombardy, Veneto, and Navarre, with a new revision tag v3.3.3. Corresponding region-specific location headings were adjusted from the previous version.
    Difference
    0.5%
    Check dated 2025-12-23T17:18:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:21:21.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The funding-related notice at the bottom of the page has been removed. It previously warned that information might not be up to date due to a lapse in government funding and that NIH operations could be affected.
    Difference
    0.3%
    Check dated 2025-11-17T18:38:35.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page content shows no significant changes to core study information (e.g., study title, conditions, locations, eligibility, primary outcomes); only minor UI and formatting updates are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:17:20.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T01:59:14.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.